0001964306-24-000011.txt : 20240118
0001964306-24-000011.hdr.sgml : 20240118
20240118162826
ACCESSION NUMBER: 0001964306-24-000011
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240118
DATE AS OF CHANGE: 20240118
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364108129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 24542177
BUSINESS ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Barton Russell
CENTRAL INDEX KEY: 0001867418
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ACUMEN PHARMACEUTICALS, INC.
STREET 2: 427 PARK STREET
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
144
1
primary_doc.xml
144
0001867418
XXXXXXXX
LIVE
0001576885
Acumen Pharmaceuticals, Inc.
001-40551
427 PARK ST.
CHARLOTTESVILLE
VA
22902
925-368-8508
Barton Russell
Officer
Common Stock
Merrill Lynch
225 Liberty St
Floor 37
New York
NY
10281
2833
10555.09
57910461
01/18/2024
NASDAQ
Common Stock
01/17/2024
Vesting of restricted stock unit award
Acumen Pharmaceuticals, Inc.
N
2833
01/17/2024
Granted as part of issuer equity compensation plan
Y
01/18/2024
09/14/2023
Russell Barton